FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

29902211000001106: Lixiana 15mg tablets (Daiichi Sankyo UK Ltd) 10 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 22-Jul 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
93198001000001112 Lixiana 15mg tablets (Daiichi Sankyo UK Ltd) 10 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
93198101000001113 Lixiana 15mg tablets (Daiichi Sankyo UK Ltd) 10 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lixiana 15mg tablets (Daiichi Sankyo UK Ltd) 10 tablet Has specific active ingredient Product containing precisely levamisole (as levamisole hydrochloride) 50 milligram/1 each conventional release oral tablet (clinical drug) false Inferred relationship Existential restriction modifier
Lixiana 15mg tablets (Daiichi Sankyo UK Ltd) 10 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lixiana 15mg tablets (Daiichi Sankyo UK Ltd) 10 tablet Has specific active ingredient Edoxaban tosilate true Inferred relationship Existential restriction modifier
Lixiana 15mg tablets (Daiichi Sankyo UK Ltd) 10 tablet Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring false Inferred relationship Existential restriction modifier
Lixiana 15mg tablets (Daiichi Sankyo UK Ltd) 10 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Lixiana 15mg tablets (Daiichi Sankyo UK Ltd) 10 tablet Is a Edoxaban 15mg tablets 10 tablet true Inferred relationship Existential restriction modifier
Lixiana 15mg tablets (Daiichi Sankyo UK Ltd) 10 tablet Has AMP Lixiana 15mg tablets (Daiichi Sankyo UK Ltd) true Inferred relationship Existential restriction modifier
Lixiana 15mg tablets (Daiichi Sankyo UK Ltd) 10 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Lixiana 15mg tablets (Daiichi Sankyo UK Ltd) 10 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lixiana 15mg tablets (Daiichi Sankyo UK Ltd) 10 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Lixiana 15mg tablets (Daiichi Sankyo UK Ltd) 10 tablet Has specific active ingredient Edoxaban tosilate false Inferred relationship Existential restriction modifier
Lixiana 15mg tablets (Daiichi Sankyo UK Ltd) 10 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Lixiana 15mg tablets (Daiichi Sankyo UK Ltd) 10 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Edoxaban false Inferred relationship Existential restriction modifier
Lixiana 15mg tablets (Daiichi Sankyo UK Ltd) 10 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Lixiana 15mg tablets (Daiichi Sankyo UK Ltd) 10 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Lixiana 15mg tablets (Daiichi Sankyo UK Ltd) 10 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Lixiana 15mg tablets (Daiichi Sankyo UK Ltd) 10 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Edoxaban false Inferred relationship Existential restriction modifier
Lixiana 15mg tablets (Daiichi Sankyo UK Ltd) 10 tablet Has basis of strength substance Edoxaban true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start